• Initiates primed MSC clinical trial for liver cirrhosis in China
  • Concludes human MSC liver study with USC
  • Begins larger animal liver study with USC
  • Expands integration of multimodal MSC treatments
  • Initiates multi-center clinical trial for FCGS